key: cord-0316910-zni3im5v
authors: Zheng, Lining; Bandara, Sarith R.; Leal, Cecilia
title: Lipid nanoparticle topology regulates endosomal escape and delivery of RNA to the cytoplasm
date: 2022-05-21
journal: bioRxiv
DOI: 10.1101/2022.05.20.492895
sha: fb001655f1d1b198ddc85808e8ca0546223521c5
doc_id: 316910
cord_uid: zni3im5v

RNA therapeutics have the potential to resolve a myriad of diseases caused by gene deficiency. Lipid nanoparticles (LNPs) are one of the most successful RNA delivery systems. However, expanding their application hinges on the discovery of next generation LNPs with high potency, cyto-specific targeting, and low side effects. Overcoming the difficulty of releasing cargo from endocytosed LNPs remains a significant hurdle. The endosomal escape of viral and non-viral nanoparticles relies on the topological transformation of membrane fusion pore formation followed by RNA translocation into the cytosol. In this study we show that LNP-RNA nanostructure modulates the energetic cost of LNP fusion with a target membrane. The inclusion of a new class of structurally-active lipids leads to superior LNP endosomal fusion, fast evasion of endosomal entrapment, and efficacious RNA delivery. Specifically, bicontinuous cubic RNA-LNPs, cuboplexes, have significantly higher endosomal escape rates and deliver more RNA compared to regular lamellar LNPs.

RNA therapeutics has gained wide attention due to its power to resolve insufficient expression of critical proteins that drive a myriad of human diseases including cancer [1] , neurodegeneration [2] , metabolic disorders [3] , among others [4] [5] [6] [7] [8] . Delivery vectors play an important role in the development of such therapeutics in preventing RNA degradation and successfully deliver RNA to target cells. Compared to viral vectors, non-viral systems have the advantage of being less immunogenic and easier to manufacture [9] . Among the different materials used for non-viral delivery, lipid nanoparticles (LNPs) have been particularly successful, as many LNP-RNA formulations are clinically available [10] [11] or have advanced to clinical trials. The first FDA approved small interfering RNA (siRNA) treatment, patisiran [12] , utilized LNPs for delivery. The effectiveness of LNPs has been further manifested by the development of lipid-mRNA (messenger RNA) vaccines for coronavirus disease 2019 (COVID-19) [13] .

Despite the astonishing progress LNP delivery achieved, many barriers are still present in realizing the full potential of LNP-RNA systems [14] . While most LNP systems are efficiently taken up by the cell via endocytosis, they often remain trapped in endosomal compartments and degrade through the endosome-lysosome acidification pathway [15] [16] [17] [18] . One of the main bottlenecks of LNP-based RNA delivery is poor endosomal escape [19] [20] . Viral delivery systems have membrane proteins that undergo a conformation change allowing them to easily fuse with the plasma or endosomal membranes to release their payload. Previous studies have shown that for LNP mediated siRNA delivery, less than 2% of the siRNA can successfully escape the endosome and reach the cytosol [21] . With low cytosolic delivery efficacy, much research has been done in attempt to improve endosomal escape and transfection efficiency of LNPs by modifying lipid compositions [22] [23] [24] . Sahay and coworkers have shown that LNPs containing cholesterol demonstrate improved delivery efficiencies, potentially caused by enhanced endosomal membrane fusion [25] . Other ways of optimizing lipid compositions also shown success [26] , such as the inclusion of ionizable lipids [27] [28] [29] . Ionizable lipids are able to stay neutral under physiological pH but become cationic under the acidic environment of endosomes, being able to electrostatically pin the endosomal membrane which may allow LNPs to destabilize it and facilitate escape [10] .

However, compared to the extensive research done exploring different lipid formulations, the nanostructure of LNPs, or the specific packing of lipids and nucleic acids into the LNP has not been fully investigated. In this paper we demonstrate that future LNP design should include a new class of structurally active lipids. Due to their amphiphilic nature, lipid molecules can form a variety of self-assembled structures in aqueous environments (Fig.1b) [40] . The optimal mechanism to boost LNPs endosomal escape is to promote LNP-endosomal membrane fusion, a process that should take place in less than 30 seconds [41] and be independent from endosome acidification or the debated "proton sponge" effect [42] [43] . The design of "fusogenic" LNPs has been exclusively attributed to tuning the molecular packing parameter of lipid molecules such that their spontaneous membrane curvature (C 0 ) is negative [44] [45] . However, the elastic energy cost of membrane fusion or, more importantly, the development of the required fusion pore is controlled by a topological transformation that should mostly depend on the Gaussian moduli of membranesκ. The membrane elastic energy can be represented by the Helfrich equation [46] [47] ,

where κ is the bending modulus, J the total/extrinsic curvature which equals the sum of the principle curvatures C 1 + C 2 , and C 0 is the spontaneous curvature. The second term comprises the Gaussian curvature K = C 1 C 2 and the Gaussian modulusκ. Taking into account the Gauss-Bonnet theorem [48] and the Helfrich framework, one can calculate that the elastic energy cost of the topological transformation from two nested membrane vesicles (E initial = 8πκ) to two fused vesicles (E f used = 4πκ) to be ∆E f usion = −4πκ [49] (Fig.1a) . It is immediately clear that modulating the Gaussian modulusκ and Gaussian curvature K will significantly impact membrane fusion events and the formation of fusion pores through which RNA cargo can be delivered into the cytosol (Fig.1c) . Of the main categories of reported LNP nanostructures (L, H II , and Q II ), positively curved vesicular lamellar phases (L) haveκ < 0 but cubosomes [50] [56] first suggested that bicontinuous cubic phases should be highly fusogenic and we conjecture that Q II LNPs have a greater potential in fusing with the endosomal membrane and successfully release their cargo (Fig.1c) .

In this paper we show that the structure of LNP-RNA complexes plays a dominant role in the extent of endosomal-membrane fusion and we enable new design principles for the development of highly efficient LNP-based RNA delivery systems.

In our study, we judiciously select specific neutral lipid molecular systems and compositions to control the nanostructure of LNP-RNA complexes. Glycerol monooleate (GMO) is a neutral lipid approved by the Food and Drug Administration (FDA) for in vivo use and is utilized as an adjuvant [57] [58] . GMO is well-known to be stable into a variety of bicontinuous cubic phases [59] that be formulated into cubosome LNPs (Q II ) encapsulating siRNA which we termed as cuboplexes [35] [36] . The cuboplex LNP formulation comprised GMO, a cationic lipid 1,2-dioleoyl-3-trimethylammonium propane (DOTAP) Modulating the amount of neutral lipid GMO in the ternary GMO, DOTAP, and DOPE-PEG mixture results into precise tuning of different bicontinuous cubic structures of distinct space groups (Ia3d -gyroid, Im3m -primitive, and P n3m -diamond) as well as the formation of hexagonal phases (H II ) [35] [30] . To form the traditional lamellar phase (L), GMO contents are low (<25 mol%) [30] or the neutral lipid was switched to a phosphatidylcholine 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC). LNP-RNA complexes are formed with an optimal [35] charge ratio of ρ=3, where charge ratio represents the number of positive charges from lipid molecules (n DOT AP ) over the number of negative charges from RNA (n N A ). When nucleic acid is added to the lipid systems the nanostructures are mostly conserved but there is a preference to adopt H II phases as the 1D straight cylindrical water channels can accommodate long chain nucleic acids [63] . Fig. 2 ratio 85/14/1) composition show four distinct diffraction peaks that indicate the presence of a bicontinuous cubic gyroid nanostructure (Q II ) coexisting with a 2D inverse hexagonal phase (H II ) (Fig. 2a) . The first two peaks show reciprocal lattice vectors q/(2π/a) = G hkl /(2π/a) = (h 2 + k 2 + l 2 ) 1/2 = √ 6, √ 8, which corresponds to the {211}, {220} planes of a Q II gyroid phase. The first, third and fourth peaks show reciprocal lattice vectors q/(4π/a Table 1 ).

The interaction between endosomes and LNP-RNA complexes of different nanostructures in − vitro were explored using confocal laser scanning microscopy (CLSM), fluorescence resonance energy transfer (FRET) assays, and live-cell self-quenching CLSM experiments (Fig. 3 ). Fig. 3a shows CLSM images of isolated endosomes incubated with pure LNPs (no RNA) having the L (liposome) and Q II cubosomes nanostructures. Endosomes were isolated by standard spin-column techniques from HeLa cells and fluorescently labeled by incubating in 20µM Nile Red. The LNPs were tagged with 0.1% 1,1'-dioctadecyl-3,3,3',3'-tetramethylindodicarbocyanine (DiD). LNPs do not aggregate significantly on their own but when incubated with endosomes, LNPendosome fusion and aggregation is readily visible by co-localization of DiD and Nile Red fluorescence in both systems but is significantly more pronounced for Q II LNPs. After observing that Q II LNPs bind with isolated endosomes more favorably, we conducted a FRET assay [64] to evaluate the extent of the fusion process between endosomes and RNA-loaded LNPs of different nanostructures. Isolated endosomes were co-labeled with 1,1'dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI) and 3,3'dioctadecyloxacarbocyanine perchlorate (DiO), with DiO acting as a donor fluorophore and DiI acting as an acceptor fluorophore. The proximity of the dye molecules enables FRET to occur leading to enhanced acceptor (DiI) fluorescence. If endosomes fuse with another membrane, the dye molecules diffuse, increasing the distance between each other and FRET occurrences diminish. Reduced FRET allows donor (DiO) fluorescence to recover. Thus, the extent of membrane fusion can be evaluated by the increase in DiO fluorescence. To see how LNP structure influences LNP-endosome membrane fusion, we prepared LNP-siRNA complexes with same DOTAP molar fractions (Φ DOT AP = 0.14) but different GMO molar fractions. At Φ GM O = 0.85 RNA-loaded LNPs display the Q II structure (in coexistence with H II ) termed cuboplexes [35] [36] and at Φ GM O = 0 the lamellar L phase (Fig. 2) termed lipoplexes. Fig. 3b shows Cryogenic electron microscopy (Cryo-EM) images of cuboplexes and lipoplexes LNPs [36] . The intensity of DiO fluorescence as a function of time (Fig. 3c) is significantly higher for LNPs comprising Φ GM O = 0.85 (blue data points) compared to Φ GM O = 0 (green data points). This is consistent with a considerably higher extent of fusion of endosomes with ′′ non-lamellar ′′ LNPs (Q II /H II compared to regular "lipoplex" LNPs. Additional data is shown in Supplementary Fig. 2. .

The fact Q II RNA-loaded LNPs fuse with isolated endosomes side-by-side on a glass slide is encouraging for their application as fusogenic LNPs for RNA delivery but this is not representative of the fusion process in live cells where LNPs have to break out of an enclosing endosomal membrane. To evaluate how LNPs of different nanostructures fuse with the entrapping endosomal membranes in live cells we conducted a fluorescence self-quenching experiment in live HeLa cells (Fig. 3d,e) . We employed two types of siRNA-loaded LNPs: cuboplexes (Q II ) and lipoplexes (L)) labeled with high molar percentages (1%) of a self-quenching dye, DiD [65] [66] . When the membranes of the LNP-siRNA complexes fuse with endosomes, DiD molecules will diffuse across the membrane, reducing the self-quenching of DiD and increasing its fluorescence. Fig. 3d ,e displays the obtained DiD fluorescence recovery at three time points (1, 3, and 5 h) after incubation with L (Fig. 3d, lipoplexes) and Q II (Fig.  3e , cuboplexes) siRNA loaded LNPs. As time progresses, an increasing DiD signal (red fluorescence signal) is observed in cells treated with cuboplexes, indicating that indeed LNPs successfully fused with the endosomal membrane that internalized them. Comparatively at the same time point, cells treated with lipoplexes show little DiD fluorescence recovery, implying less effective endosomal membrane fusion. These results show that the nanostructure of LNP-RNA complexes plays a critical role in their ability to fuse and break out of endosomal compartments.

We next investigated if the ability for Q II RNA-loaded LNPs (cuboplexes) to efficiently fuse with endosomal membranes translates to better delivery of cargo and more efficient endosomal escape. Uptake of siRNA in epithelial human cervix cancer (HeLa) and murine breast cancer (4T1) cells were quantified by flow cytometry (Fig. 4a) . To verify that the siRNA signal is not from siRNA outside the cell membrane or from dead cells, trypan Blue (TB) was added to quench the fluorescence of siRNA outside the cellular membrane and that of membrane compromised cells [67] [68] . The results show that HeLa cells treated with cuboplexes have significantly more cytoplasmic siRNA compared to cells treated with lipoplexes, and the siRNA uptake is comparable to that of Lipofectamine (LFA), a commercially available siRNA transfection agent. Hela cells are well-known to be relatively easy to transfect, however, in more resilient cells lines like 4T1 murine breast cancer epithelial cells [69] , we observe that cuboplexes continue to outperform lipoplexes in siRNA delivery capabilities.

To test the hypothesis that cuboplexes deliver more RNA to cells compared to lipoplexes because they more effectively fuse and break out of endosomal entrapment, we utilized live cell imaging to compare the cell internalization as well as endosomal entrapment of these two different LNP-RNA complexes (Fig. 4b) . DiO labeled LNP-siRNA complexes (shown as red) were added to HeLa cells stained with Hoeschst nuclei dye (blue) and imaged as a function of time (0, 30, 60, and 120 min). The higher amount of red signal around the nuclei would correspond to a higher extent of nanoparticle internalization (Fig. 4 c,e) . Lipoplexes show lower levels of internalization by HeLa cells compared to cuboplexes. To investigate the endosomal entrapment of the different LNP-siRNA complexes, early endosomes of HeLa cells were labeled with a fusion construct of Rab5a-GFP (shown as green). The cells were treated with LNP-siRNA complexes prepared with siRNA fluorescently labeled with Fig. 4 Cuboplexes deliver siRNA more effectively compared to lipoplexes. a, Uptake of siRNA in HeLa cells and 4T1 cells quantified by flow cytometry. Trypan Blue (TB) was added to quench the fluorescence of siRNA outside the cellular membrane and that of membrane compromised cells (n = 3, data presented as mean ± s.d.). Significance between groups were calculated with two-sided Student's t-test and indicated as *P ≤ 0.05, **P ≤ 0.01 or ***P ≤ 0.001. b, Schematic representation of live cell imaging experiments evaluating the internalization and siRNA endosomal entrapment of LNP-RNA complexes. c-d, HeLa cells were treated with DiO labeled LNP-siRNA complexes (red) and imaged every 5 min. Less lipoplexes (c) enter the cells compared to cuboplexes (d). Scale bar, 10 µm. e-f, Endosome labeled cells were treated with cuboplexes (e) and lipoplexes (f ) containing AF546-siRNA and imaged every 5 min. Less siRNA (red) are entrapped in the endosome in cuboplex treated cells compared to those treated with lipoplexes. Scale bar, 10 µm. Significance between groups were calculated with two-sided Student's t-test and indicated as *P ≤ 0.05, **P ≤ 0.01 or ***P ≤ 0.001.

Alexa Fluor 546 (AF546), shown as red, and monitored over time (5, 15, 30 , and 60 min). When siRNA resides entrapped in the endosome, the fluorescent signal of siRNA and endosome would co-localize, appearing as yellow. Less colocalization, or yellow, would be an indication of less endosomal entrapment and more occurrences of successful endosomal escape. In Fig. 4 d,f, compared to lipoplexes, cuboplexes showed less co-localization with the endosomes, indicating less cuboplexes were entrapped. Combined, lipoplexes show low levels of internalization and high amounts of siRNA-endosome co-localization (Fig. 4 c,d) throughout the investigated timeline of up to 2h (internalization) and 1h (entrapment). This indicates that cuboplexes have superior ability not only to get internalized by cells at faster rates but also to efficiently evade endosomal entrapment and translocate RNA into the cytosol.

We have previously shown that cuboplex LNPs are more efficient at transfecting siRNA into cells compared to lipoplexes leading to better specific gene-knockdown performance. [37] [35] [36] . When replacing siRNA for mRNA LNPs retain their structural identity (Fig. 2 ) as well as their shape and size (Supplementary table 1) . Fig. 5a ,b shows images of nanoparticle tracking analysis (NTA) of cuboplex LNPs loaded with siRNA (a) and mRNA (b). Using cuboplex LNPs to deliver mRNA to cells leads to much more efficient activation of luciferase expression (Fig. 5c ) compared to parent lipoplex mRNA-LNPs. A plasma membrane integrity assay confirmed that all LNP-RNA complexes used in this study have negligible cytotoxicity (Supplementary Fig.3) .

In this study, we were able to show that nanostructures have a significant impact on the endosomal escape of LNP-RNA delivery systems. Compared to lamellar structured LNP-RNA complexes, cubic and inverse hexagonal structured LNP-RNA complexes are able to fuse with endosomal membranes easier, hence leading to higher extent of endosomal escape. These findings provide valuable insight in how nanostructures can affect nanoparticle-cell interactions, but also highlight the potential in utilizing structurally active lipids and nanoparticle structure as an additional handle to controlling the efficacy of drug delivery systems.

Endosomal escape has been a major hurdle in the development of successful RNA therapeutics. Our studies were able to show that by controlling the nanostructure of LNP-RNA complexes, we can influence the efficiency of endosomal escape without any aid from proteins, endosome acidification, or lipid ionization. Specifically, complexes with cubic structures are able to promote membrane fusion between LNPs and endosomal membranes. This is possible due to their intrinsic ability to lower the elastic cost of the topological transformation from an endosome with a nested LNP to a fused LNP-endosome state having a pore through which RNA can be transported into the cytosol. This enhancement in endosomal escape for cuboplexes led to better RNA delivery compared to its lipoplex counterparts. These results show that nanostructure, and the inclusion of structurally active lipids, is an important factor in designing non-viral delivery systems, and more research is required to fully unravel how nanoparticles of various structures interact with cells. 

Lipid chloroform solutions were mixed at desired volumetric ratios. Chloroform was removed by treating the solution with a stream of nitrogen and then placing it under vacuum for at least 8 hrs. DOPE-PEG was dried in a separate vial. The dried lipid film was hydrated with sterile Milli-Q water and incubated overnight at 37°C. LNPs were obtained by sonicating the suspension with a cup horn system (Fisher Scientific) for 6 min at 100 % amplitude. The temperature was maintained at below 4°C during sonication by a water chiller (Qsonica). The LNPs were transferred to the vial with dried DOPE-PEG and incubated for 1 hr at 60°C for post pegylation.

LNP-RNA complexes were formed by mixing LNPs with siRNA or mRNA at a charge ratio ρ (n DOTAP /n NA ) of 3.

20 mM LNP-RNA complexes were prepared and transferred to quartz capillaries (Hilgenberg Glas, Germany). Synchrotron SAXS were performaed at beamline 12-ID-B of the Advanced Photon Source at Argonne National Laboratory. The average photon energy was 14 keV and the data was radially averaged upon acquisition on a Pilatus 2M detector.

HeLa cells (ATCC), 4T1 cells (ATCC) and HeLa-Luc cells (Signosis) were cultured in full cell media consisting of Dulbecco's modified Eagle's medium (Corning), 10% fetal bovine serum (Gibco) and 1% penicillin-streptomycin (Gibco) at 37°C with 5% of carbon dioxide.

Endosomes were isolated with Trident endosome isolation kit (GeneTex). Particle concentration and size were measured by nanoparticle tracking analysis with Nanosight NS300 (Malvern Panalytical).

For confocal microscopy analysis, DiD (Biotum) labeled LNPs were prepared by including 0.1% DiD in the lipid mixture. Endosomes were labeled by incubating with 20 µM NileRed for 1 hr at 37°C. Free dye was removed from endosomes by centrifuging for 30 min at 10,000 × g and discarding the supernatant. The endosomes were resuspended in PBS and incubated with DiD labeled LNPs for 6 hrs at 37°C. The mixture was imaged on an LSM 800 (Carl Zeiss) confocal microscope.

For FRET assay, endosomes were incubated with 20 µM DiO and 20 µM DiI for 1 hr at 37°C for colabeling. Free dye was removed and endosomes were resuspended in PBS. Endosomes and lipid-siRNA complexes were incubated at 37°C and measured for DiO fluorescence every 5 minutes. Fluorescence was detected with Synergy Neo 2 microplate reader (Biotek).

Labeled LNP-siRNA complexes were prepared by including 0.1% DiI in the lipid mixture. HeLa-Luc were cultured on coverslip bottom dishes (ibidi) and stained with Hoescht dye. Complexes were added to the cells and imaged immediately on an LSM 800 (Carl Zeiss) confocal microscope. 405 nm laser was used for the Hoescht dye channel and 488 nm laser was used for DiO and DiI. Images were acquired every 5 minutes for 3 hrs. Cells were seeded onto poly-lysine coated glass bottom dishes at 1,000 cells/cm 2 density, and CellLight TM Early Endosomes-GFP reagent(Thermo Fisher Scientific) was added after cell adherence. After 16 hours of incubation, complexes with Alexa Fluor 546 labeled siRNA were added to the cells with a final siRNA concentration of 33 nM. The dish were observed immediately under confocal microscopy. Images were acquired every 5 minutes for 4 hrs.

Cells were seeded onto 12-well plates at 1,000 cells/cm 2 density prior to transfection. The following day, complexes were added to the cells with a final siRNA concentration of 33 nM, and then incubated for 24 hrs. After incubation, the cells were trypsinized and washed with PBS. Cells were later suspended in FACS buffer (98% PBS, 2% FBS) and analyzed by flow cytometry (BD LSR-Fortessa X-20). After the sample data was acquired, 0.4% Trypan blue was added to the samples at a 1:10 ratio and analyzed by flow cytometry.

Cells were seeded onto 96-well plates at 1,000 cells/cm 2 density prior to transfection. The following day LNP-mRNA complexes were added to the cells with 0.2 µg mRNA per well. The cells were incubated for 24 hrs and the luciferase activity was evaluated by a luciferase assay (Promega). Luminescence was measured with Synergy Neo 2 microplate reader (Biotek), and normalized by the cell protein mass of each well. Cell protein mass was quantified by BCA assay (Thermo Fisher Scientific).

YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Non-coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases

CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency

The current landscape of nucleic acid therapeutics

mRNA vaccinesa new era in vaccinology

Mutations in SYNGAP1 Cause Intellectual Disability, Autism, and a Specific Form of Epilepsy by Inducing Haploinsufficiency

The PMP22 Gene and Its Related Diseases

Non-viral is superior to viral gene delivery

Lipid nanoparticles for mRNA delivery

Next-Generation Lipids in RNA Interference Therapeutics

FDA approves patisiran to treat hereditary transthyretin amyloidosis

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

Better lipids to power next generation of mRNA vaccines

Brief update on endocytosis of nanomedicines

Carriers Break Barriers in Drug Delivery: Endocytosis and Endosomal Escape of Gene Delivery Vectors

Mechanism of Polyplex-and Lipoplex-Mediated Delivery of Nucleic Acids: Real-Time Visualization of Transient Membrane Destabilization without Endosomal Lysis

Endocytosis and autophagy: Shared machinery for degradation

Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown

Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling

Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape

Rational design of cationic lipids for siRNA delivery

Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs

Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA

Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA

Drug delivery systems for RNA therapeutics

Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia

A Novel Amino Lipid Series for mRNA Delivery: Improved Endosomal Escape and Sustained Pharmacology and Safety in Non-human Primates

Membrane-destabilizing ionizable phospholipids for organselective mRNA delivery and CRISPR-Cas gene editing

The stabilization of primitive bicontinuous cubic phases with tunable swelling over a wide composition range

Super-swelled lyotropic single crystals

Self-organization of nucleic acids in lipid constructs

Near-Infrared-Triggered Reversible Transformations of Gold Nanorod-Laden Lipid Assemblies: Implications for Cellular Delivery

Lipid-based liquid crystalline films and solutions for the delivery of cargo to cells

Cuboplexes: Topologically Active siRNA Delivery

Microfluidics Synthesis of Gene Silencing Cubosomes

Highly Efficient Gene Silencing Activity of siRNA Embedded in a Nanostructured Gyroid Cubic Lipid Matrix

Optimizing cationic and neutral lipids for efficient gene delivery at high serum content: Lipoplexes resistant to high serum

Hexosomes: A novel drug delivery system

Nanogyroids Incorporating Multivalent Lipids: Enhanced Membrane Charge Density and Pore Forming Ability for Gene Silencing

Pathological cardiolipin-promoted membrane hemifusion stiffens pulmonary surfactant membranes

The proton sponge hypothesis: Fable or fact?

The Possible "Proton Sponge " Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH

The Energetics of Membrane Fusion from Binding, through Hemifusion, Pore Formation, and Pore Enlargement

Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency

Elastic Properties of Lipid Bilayers: Theory and Possible Experiments

Recherches sur la théorie des surfacesélastiques

The Language of Shape

biomembrane curvature and remodeling roadmap

The Next Generation of Smart Lipid Nanoparticles?

Inverted micellar intermediates and the transitions between lamellar, cubic, and inverted hexagonal lipid phases. ii. implications for membrane-membrane interactions and membrane fusion

The mechanism of lamellar-to-inverted hexagonal phase transitions in phosphatidylethanolamine: Implications for membrane fusion mechanisms

Inverted micellar intermediates and the transitions between lamellar, cubic, and inverted hexagonal amphiphile phases. iii. isotropic and inverted cubic state formation via intermediates in transitions between lα and h II phases

Determining the Ratio of the Gaussian Curvature and Bending Elastic Moduli of Phospholipids from QII Phase Unit Cell Dimensions

The Gaussian Curvature Elastic Modulus of N-Monomethylated Dioleoylphosphatidylethanolamine: Relevance to Membrane Fusion and Lipid Phase Behavior

Membrane fusion and inverted phases

Cfr-code of federal regulations title 21

Glyceryl monooleate-coated bioadhesive hollow microspheres of riboflavin for improved gastroretentivity: Optimization and pharmacokinetics

Two cubic phases in monoolein-water system

Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes

Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells

PEG-Lipid Post Insertion into Drug Delivery Liposomes Quantified at the Single Liposome Level

Stacking of short DNA induces the gyroid cubic-to-inverted hexagonal phase transition in lipid-DNA complexes

Rapid Detection of Exosomal MicroRNAs Using Virus-Mimicking Fusogenic Vesicles

Visualization of targeted transduction by engineered lentiviral vectors

Visualizing infection of individual influenza viruses

Competition of charge-mediated and specific binding by peptide-tagged cationic liposome-DNA nanoparticles in vitro and in vivo

Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes

Nanoparticles as transfection agents: A comprehensive study with ten different cell lines